These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14659433)

  • 1. Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations.
    Schleyer E; Pursche S; Köhne CH; Schuler U; Renner U; Gschaidmeier H; Freiberg-Richter J; Leopold T; Jenke A; Bonin M; Bergemann T; le Coutre P; Gruner M; Bornhäuser M; Ottmann OG; Ehninger G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):23-36. PubMed ID: 14659433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
    Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
    J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatography method with ultraviolet detection for the quantification of the BCR-ABL inhibitor nilotinib (AMN107) in plasma, urine, culture medium and cell preparations.
    Pursche S; Ottmann OG; Ehninger G; Schleyer E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):208-16. PubMed ID: 17291840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
    Miura M; Takahashi N; Sawada K
    J Chromatogr Sci; 2011 May; 49(5):412-5. PubMed ID: 21549035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
    Tan KL; Ankathil R; Gan SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3583-91. PubMed ID: 22000961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.
    le Coutre P; Kreuzer KA; Pursche S; Bonin Mv; Leopold T; Baskaynak G; Dörken B; Ehninger G; Ottmann O; Jenke A; Bornhäuser M; Schleyer E
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):313-23. PubMed ID: 14658008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.
    Neville K; Parise RA; Thompson P; Aleksic A; Egorin MJ; Balis FM; McGuffey L; McCully C; Berg SL; Blaney SM
    Clin Cancer Res; 2004 Apr; 10(7):2525-9. PubMed ID: 15073132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry.
    Guetens G; De Boeck G; Highley M; Dumez H; Van Oosterom AT; de Bruijn EA
    J Chromatogr A; 2003 Dec; 1020(1):27-34. PubMed ID: 14661754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
    Zhang M; Moore GA; Fernyhough LJ; Barclay ML; Begg EJ
    Anal Bioanal Chem; 2012 Oct; 404(6-7):2091-6. PubMed ID: 22865010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.
    Parise RA; Ramanathan RK; Hayes MJ; Egorin MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):39-44. PubMed ID: 12798163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an HPLC method for determination of imatinib mesylate in rat serum and its application in a pharmacokinetic study.
    Bende G; Kollipara S; Movva S; Moorthy G; Saha R
    J Chromatogr Sci; 2010; 48(5):334-41. PubMed ID: 20515524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of grepafloxacin in plasma and urine by a simple and rapid high-performance liquid chromatographic method.
    Kamberi M; Kamberi P; Nakano S
    J Chromatogr B Biomed Sci Appl; 2000 May; 741(2):295-300. PubMed ID: 10872599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples.
    Velpandian T; Mathur R; Agarwal NK; Arora B; Kumar L; Gupta SK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):431-4. PubMed ID: 15081939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography.
    Davies A; Hayes AK; Knight K; Watmough SJ; Pirmohamed M; Clark RE
    Leuk Res; 2010 Jun; 34(6):702-7. PubMed ID: 20004471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecin derivative, in human plasma and urine.
    Smith JA; Hausheer F; Newman RA; Madden TL
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):117-24. PubMed ID: 11499615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of imatinib mesylate in healthy volunteers.
    Gschwind HP; Pfaar U; Waldmeier F; Zollinger M; Sayer C; Zbinden P; Hayes M; Pokorny R; Seiberling M; Ben-Am M; Peng B; Gross G
    Drug Metab Dispos; 2005 Oct; 33(10):1503-12. PubMed ID: 16006570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of imatinib targeted delivery in human leukocytes.
    Kralj E; Žakelj S; Trontelj J; Pajič T; Preložnik Zupan I; Černelč P; Ostanek B; Marc J; Kristl A
    Eur J Pharm Sci; 2013 Sep; 50(1):123-9. PubMed ID: 23643738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a sensitive assay for the quantification of imatinib using LC/LC-MS/MS in human whole blood and cell culture.
    Klawitter J; Zhang YL; Klawitter J; Anderson N; Serkova NJ; Christians U
    Biomed Chromatogr; 2009 Dec; 23(12):1251-8. PubMed ID: 19517424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC-MS/MS assay and ultrafiltration method.
    Arellano C; Gandia P; Lafont T; Jongejan R; Chatelut E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():94-100. PubMed ID: 23000741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed-phase high-performance liquid chromatography.
    Oostendorp RL; Beijnen JH; Schellens JH; Tellingen Ov
    Biomed Chromatogr; 2007 Jul; 21(7):747-54. PubMed ID: 17385801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.